Search - tctmd.com

Displaying 41 - 60 of 72

Sort: Relevancy | Date

News Conference News ESC 2017

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Yael L. Maxwell

September 01, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Conference News ESC 2016

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

Shelley Wood

August 30, 2016

News Conference News ESC 2016

Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2

Michael O'Riordan

August 29, 2016

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

September 04, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

Advertisement

Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS

Cardiac MRI and SPECT Reduce Unnecessary Angiograms vs Guideline-Directed Care in Suspected CAD: CE-MARC2

ABSORB Trials Pit BRS Against Second-Generation DES

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

FFR-Guided CABG Reduces Number of Grafts in Patients with Intermediate Stenosis

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content